Tyler Artner
Impact in
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immune cells in cancer
- Atherosclerosis and Cardiovascular Diseases
-
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 8
- Immune cells in cancer 2
- Immune Response and Inflammation 1
-
- CRISPR and Genetic Engineering 2
- Co-authors
- Iréne Lang (10 shared papers)Smriti Sharma (6 shared papers)Andreas Mangold (6 shared papers)Anna S. Ondracek (8 shared papers)Thomas M. Hofbauer (7 shared papers)Robert Winker (2 shared papers)Klaus T. Preissner (2 shared papers)Walter Klepetko (1 shared paper)
In The Last Decade
Tyler Artner
13 papers receiving 231 citations
Peers
Comparison fields: 5 of 49
- Immunology 114
- Internal Medicine 17
- Cancer Research 30
- Cardiology and Cardiovascular Medicine 37
- Immunology and Allergy 10
Countries citing papers authored by Tyler Artner
This map shows the geographic impact of Tyler Artner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tyler Artner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tyler Artner more than expected).
Fields of papers citing papers by Tyler Artner
This network shows the impact of papers produced by Tyler Artner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tyler Artner. The network helps show where Tyler Artner may publish in the future.
Co-authors
The 25 scholars most cited alongside Tyler Artner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 116 | |
| 2 | 2019 | 33 | |
| 3 | 2021 | 27 | |
| 4 | 2024 | 13 | |
| 5 | 2024 | 12 | |
| 6 | 2022 | 10 | |
| 7 | 2024 | 7 | |
| 8 | 2024 | 6 | |
| 9 | 2021 | 3 | |
| 10 | 2025 | 2 | |
| 11 | 2023 | 1 | |
| 12 | 2024 | 1 | |
| 13 | 2021 | 1 |
About Tyler Artner
Tyler Artner is a scholar working on Immunology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Cardiology and Cardiovascular Medicine, having authored 13 papers that have together received 232 indexed citations. Recurring topics across this work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (8 papers), Vasculitis and related conditions (2 papers), Immune cells in cancer (2 papers), Cancer-related molecular mechanisms research (2 papers), CRISPR and Genetic Engineering (2 papers), Immune Response and Inflammation (1 paper), Nitric Oxide and Endothelin Effects (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Immunology (114 citations), Internal Medicine (17 citations), Cancer Research (30 citations), Cardiology and Cardiovascular Medicine (37 citations) and Immunology and Allergy (10 citations). Tyler Artner has collaborated with scholars based in Austria, Germany and Israel. Frequent co-authors include Iréne Lang, Smriti Sharma, Andreas Mangold, Anna S. Ondracek, Thomas M. Hofbauer, Robert Winker, Klaus T. Preissner, Walter Klepetko, Shahrokh Taghavi and Adelheid Panzenboeck. Their work appears in journals such as Blood, European Heart Journal, Atherosclerosis, European Journal of Clinical Investigation and JACC Basic to Translational Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.